Dr. Scott Gottlieb on Novo Nodrisk’s oral diabetes drug, future of weight-loss drugs
Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss news of Novo Nordisk’s oral diabetes drug cutting heart-related risks in patients, state of…
Thought Leader: Scott Gottlieb